VAERS reports by lot

GSK Varicella/Shingles lot G72ZD: VAERS reports

69 VAERS reports list lot G72ZD as a GSK Varicella/Shingles vaccine, received between 2019-01-28 and 2021-05-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
69
Reports
1%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5823%
Injection-site / Local reaction4719%
Neurological3313%
Musculoskeletal3213%
Dermatological (non-injection-site)2811%
Gastrointestinal218%
Allergic / Anaphylactic125%
Cardiac / Cardiovascular73%
Respiratory62%
Psychiatric / Neuropsychiatric31%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Colorado6
Minnesota5
Florida4
Pennsylvania4
Ohio3
Michigan3
Illinois3
Iowa3
Arizona2
Idaho2
Washington2

Reports by month received

2019-012
2019-0223
2019-0312
2019-0410
2019-055
2019-066
2019-072
2019-081
2019-093
2019-101
2020-021
2020-041
2020-051
2021-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.